Related Experiment Video
Updated: Jun 18, 2026
07:32
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
Published on: September 1, 2023
[Immunogenicity of Staphylococcus aureus recombinant clumping factor A].
Hao Feng1, Lefeng Liu, Jiaqi Chi
1School of Life Science and Technology, Heilongjiang Bayi Agricultural University, Daqing 163319, China.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|November 27, 2009
Summary
The Staphylococcus aureus surface protein Clumping factor A (ClfA) demonstrates significant immunogenicity and immunoprotective potential. Antibodies generated against recombinant ClfA conferred partial protection against S. aureus challenge in mice.
Area of Science:
- Microbiology
- Immunology
- Protein Engineering
Background:
- Staphylococcus aureus (S. aureus) is a major human pathogen.
- Clumping factor A (ClfA) is a key surface protein involved in S. aureus virulence.
- Understanding ClfA's immunogenicity is crucial for developing effective vaccines.
Purpose of the Study:
- To characterize the immunogenicity and immunoprotection of S. aureus Clumping factor A (ClfA).
- To assess the potential of recombinant ClfA as a vaccine candidate.
Main Methods:
- Amplification and cloning of clfa genes from different S. aureus strains.
- Expression and purification of recombinant ClfA protein in Escherichia coli.
- Immunization of mice with recombinant ClfA and measurement of antibody titers and cytokine levels.
- Challenge assays with S. aureus strains to evaluate immunoprotection.
Main Results:
- The clfa gene sequences were found to be highly conserved across tested strains.
- Recombinant ClfA was successfully expressed and exhibited good antigenicity.
- Immunization with recombinant ClfA significantly increased antibody titers and cytokine levels in mice (P < 0.05).
- Immunized mice showed partial protection against S. aureus challenge.
Conclusions:
- Clumping factor A (ClfA) possesses high immunogenicity.
- Recombinant ClfA demonstrates significant immunoprotective potential.
- ClfA is a promising target for developing vaccines against S. aureus infections.
Related Concept Videos
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:20Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:51Vaccinations
Overview
01:27Streptococcal Pharyngitis
Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...